SEC Filing Document

Company: DUKE Robotics Corp.
Ticker: DUKR
CIK: 1638911
Filing Type: DRS
Document Type: DRS
Date Filed: 2025-12-22
Accession Number: 0001213900-25-124553
Exchange: OTC
SIC Code: 3721
SIC Description: Aircraft
URL: https://www.sec.gov/Archives/edgar/data/1638911/000121390025124553/filename1.htm

Chunk 9 of 51
Word Count: 1456
Character Count: 8920

Document Content:

occur, the market price of our common stock could decline. Any such sales, or the perception that they may occur, could also impair our ability to raise additional capital through the sale of equity or equity-linked securities in the future. If we fail to maintain our listing on Nasdaq and our common stock once again becomes subject to the “penny stock” rules, it may be more difficult for investors to sell their shares. Prior to our proposed listing on the Nasdaq, our common stock has been quoted on the OTCQB and, during that time, has been subject to the “penny stock” rules under the Exchange Act. Securities subject to the penny stock rules are generally equity securities with a market price of less than $5.00 per share that are not listed on a national securities exchange and that do not otherwise qualify for an exemption from the penny stock definition.

While we expect that, upon
and for so long as our common stock is listed on Nasdaq and we satisfy the applicable quantitative listing standards, our common stock
will not be considered a penny stock, there can be no assurance that we will be able to maintain such listing. If, in the future, our
common stock ceases to be listed on a national securities exchange and does not otherwise qualify for an exemption, it could again become
subject to the penny stock rules. In that event, broker-dealers effecting transactions in our common stock would be subject to additional
sales practice and disclosure requirements, including making a special written suitability determination and obtaining the purchaser’s
written agreement to the transaction. These additional burdens may discourage broker-dealers from effecting transactions in our common
stock, which could reduce liquidity and have an adverse effect on the market price of our common stock.

The sales practice requirements
of FINRA may also limit a stockholder’s ability to buy and sell our stock.

In addition to the “penny
stock” rules described above, FINRA has adopted Rule 2111 that requires a broker-dealer to have reasonable grounds for believing
that an investment is suitable for a customer before recommending the investment. Prior to recommending speculative low-priced securities
to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial
status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a
high probability that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements make
it more difficult for broker-dealers to recommend that their customers buy the Company’s common stock, which may limit your ability
to buy and sell the Company’s stock and have an adverse effect on the market for our shares.

Investors in this offering
will experience immediate and substantial dilution in net tangible book value.

The public offering price
of the shares of common stock included in the Units will be substantially higher than the net tangible book value per share of our outstanding
shares of common stock. As a result, investors in this offering will incur immediate dilution of $[____] per share based on the public
offering price of $[____] per Unit. Investors in this offering will pay a price per Unit that substantially exceeds the book value of
our assets after subtracting our liabilities. See “Dilution” for a more complete description of how the value of your investment
will be diluted upon the completion of this offering.

Our management will
have broad discretion over the use of proceeds from this offering and may not use the proceeds effectively.

Our management will have broad
discretion over the use of proceeds from this offering. We intend to use the net proceeds from this offering for research and development, sales force expansion, marketing, business
development and potential acquisitions and for general working capital.
Our management will have considerable discretion in the application of the net proceeds, and you will not have the opportunity, as part
of your investment decision, to assess whether the proceeds are being used appropriately. The net proceeds may be used for corporate purposes
that do not improve our operating results or enhance the value of our securities.

Our expected use of net proceeds
from this offering represents our current intentions based upon our present plans and business condition. As of the date of this prospectus,
we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering.
The amounts and timing of our actual use of the net proceeds will vary depending on numerous factors, including amount of cash used in
our operations, which can be highly uncertain, subject to substantial risks and can often change. Our management will have broad discretion
in the application of the net proceeds, and investors will be relying on our judgment regarding the application of the net proceeds of
this offering.

The warrants included
in the Units are speculative in nature.

The warrants included in the Units offered in this offering do not
confer any rights of common stock ownership on their holders, such as voting rights or the right to receive dividends, but rather merely
represent the right to acquire shares of our common stock at a fixed price for a limited period of time. Specifically, commencing on the
date of issuance, holders of such warrants may exercise their right to acquire shares of common stock and pay an exercise price of $[____]
per share ([_]% of the public offering price of a Unit), prior to five years from the date of issuance, after which date any such unexercised
warrants will expire and have no further value. In addition, there is no established trading market for such warrants and we do not expect
a market to develop.

Holders of the warrants
included in the Units offered hereby will have no rights as a common stockholder until they acquire our common stock.

Until holders of the warrants
included in the Units offered hereby acquire shares of our common stock upon exercise of the warrants, the holders will have no rights
with respect to shares of our common stock issuable upon exercise of the warrants. Upon exercise of the warrants, the holder will be entitled
to exercise the rights of a common stockholder as to the security exercised only as to matters for which the record date occurs after
the exercise.

Provisions of the warrants
offered by this prospectus could discourage an acquisition of us by a third party.

In addition to the discussion
of the provisions of our Articles of Incorporation, as amended, our amended by-laws, certain provisions of the warrants included in the
Units offered by this prospectus could make it more difficult or expensive for a third party to acquire us. Such warrants prohibit us
from engaging in certain transactions constituting “fundamental transactions” unless, among other things, the surviving entity
assumes our obligations under such warrants. These and other provisions of the warrants included in the Units offered by this prospectus
could prevent or deter a third party from acquiring us even where the acquisition could be beneficial to you.

Even if the Board approves
a reverse stock split of our common stock at a ratio that currently achieves the requisite increase in the market price of our common
stock for listing of our common stock on Nasdaq, we cannot assure you that the market price of our common stock will remain high enough
for such reverse split to have the intended effect of complying with Nasdaq’s minimum bid price requirement; and if we effect a
reverse stock split, we cannot assure you that we will meet Nasdaq’s minimum requirements or standards.

Even if the reverse stock
split achieves the requisite increase in the market price of our common stock to be in compliance with the minimum bid price of Nasdaq,
there can be no assurance that (i) the market price of our common stock following the reverse stock split will remain at the level required
for continuing compliance with that requirement, or (ii) if we effect a reverse stock split, we will meet Nasdaq’s minimum requirements
or standards. It is not uncommon for the market price of a company’s common stock to decline in the period following a reverse stock
split. If the market price of our common stock declines following the effectuation of the reverse stock split, the percentage decline
may be greater than would occur in the absence of a reverse stock split. In any event, other factors unrelated to the number of shares
of our common stock outstanding, such as negative financial or operational results, could adversely affect the market price of our common
stock and jeopardize our ability to meet or maintain the Nasdaq’s minimum bid price requirement.